Why similar genes can lead to very different brains, a new study offers clues
Peer-Reviewed Publication
Updates every hour. Last Updated: 17-Jun-2026 19:16 ET (17-Jun-2026 23:16 GMT/UTC)
Biologists have long puzzled over why organisms with similar numbers of protein-coding genes can differ so dramatically in nervous system complexity. New research points to a potential link between the expanding diversity of RNA-binding proteins, which shape how genetic instructions are processed, and greater brain sophistication.
Researchers develop an interpretable hybrid feature selection model to overcome the "curse of dimensionality"in genomic selection, pinpointing key genetic markers for global food security.
Konstanz molecular biologist Elke Deuerling has been admitted to the German National Academy of Sciences, the "Leopoldina". By selecting Elke Deuerling as a member, the Academy recognizes her outstanding contributions to the field of life sciences, particularly to proteostasis research.
Researchers have discovered a “control switch” inside our immune cells that helps the body destroy dangerous fungal infections.
The team found that a protein called RAB5c helps white blood cells kill Aspergillus fumigatus – a common airborne fungus that can cause life‑threatening lung infections in people with weakened immune systems.
The study reveals that without this protein, immune cells are effectively disarmed – even though they appear to be attacking at full force.
The findings could have major implications for treating fungal infections – which are notoriously hard to diagnose and often resistant to drugs.
The team hope their breakthrough could lead to new treatments for vulnerable patients.
Dr Ainara Ballesteros is a Juan de la Cierva postdoctoral researcher at the Institute of Environment and Marine Science Research at the Catholic University of Valencia, where she leads a research group focused on jellyfish biology, aquaculture, and the sustainable use of marine resources. Her work is centered on developing innovative solutions based on marine science, particularly through the study of underused organisms as sources of high-value compounds within circular bioeconomy and zero-waste strategies.
She is joined in this work by Raquel Torres, a PhD student at the same institute, who is carrying out her doctoral thesis within this line of research, focused on jellyfish valorization, collaboration with the fishing sector, and the sustainable management of marine resources.
They are co-authors on a new Frontiers in Marine Science article which investigated whether jellyfish accidentally caught by small-scale fishers in Spain could be transformed into a valuable resource instead of being treated as waste. The team worked side by side with fishers to better understand their perceptions of jellyfish bycatch, identify which species are most frequently caught, and evaluate whether one of them, Rhizostoma pulmo, could serve as a sustainable source of high-quality collagen.
Alterations in the bacterial composition in various anatomical sites of the human body have been associated with tumorigenesis and the progression of multiple cancers; however, divergent results regarding enriched bacteria have been reported across studies of the same disease, indicating cohort-dependent bacterial compositional variance. To move beyond this inconsistency, a research team led by Professor Na Liu from Sun Yat-sen University Cancer Center proposes a fundamental shift in perspective. The team argues that it is the functional repertoire of bacterial communities, rather than their taxonomic identity, that serves as the core driver of tumor progression. The team proposes the unified nomenclature of bacterial functional constituents as “tumor-associated bacterial effectors” (TABEs), categorizing them into six functional classes according to their chemical nature, conserved structural features, and analogous mechanisms of action in regulating host cells. The researchers believe that exploring the mechanisms of TABEs in cancer represents a critical step toward harnessing their biological potential in real-life clinical settings.